Fulgent Genetics Inc (FLGT) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges [Yahoo! Finance]
Fulgent Genetics, Inc. (FLGT)
Last fulgent genetics, inc. earnings: 3/10 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.fulgentgenetics.com
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Q4 2025 Revenue: $83.3 million, a 9% increase year over year, but a slight decrease quarter over quarter. Full Year 2025 Revenue: $322.7 million, a 14% increase compared to 2024. Precision Diagnostics Q4 Revenue: $48.2 million, an 11% increase year over year, but down 5% sequentially. Anatomic Pathology Q4 Revenue: $27 million, a 3% increase year over year and up 4% sequentially. BioPharma Services Q4 Revenue: $8.1 million, a 32% increase year over year and 10% sequentially. Full Year Precision Diagnostics Revenue: $190.5 million, a 14% increase over 2024. Full Year Anatomic Pathology Revenue: $106.4 million, a 10% increase over 2024. Full Year BioPharma Services Revenue: $25.8 million, a 58% increase over 2024. Q4 2025 Gross Margin (Non-GAAP): Q4 2025 Gross Margin (GAAP): Q4 2025 GAAP Operating Expenses: $68.8 million, up from $50.9 million in the prior quarter. Q4 2025 Non-GAAP Operating Expenses: $43.1 million, compa
Show less
Read more
Impact Snapshot
Event Time:
FLGT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FLGT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FLGT alerts
High impacting Fulgent Genetics, Inc. news events
Weekly update
A roundup of the hottest topics
FLGT
News
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGTGlobeNewswire
- Fulgent Genetics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their LossesGlobeNewswire
- A Look At Fulgent Genetics (FLGT) Valuation After 2025 Results And 2026 Revenue Guidance [Yahoo! Finance]Yahoo! Finance
- Fulgent Genetics Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
FLGT
Earnings
- 2/27/26 - Beat
FLGT
Sec Filings
- 3/2/26 - Form 4
- 3/2/26 - Form 4
- 3/2/26 - Form 4
- FLGT's page on the SEC website